Elevance Health Financials

Market Capitalization $79.13 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	13.64
Forward PE	10.02
Price to Sales TTM	$0.43
Price to Book MRQ	$1.86
Enterprise to Revenue	0.46
Enterprise to EBITDA	8.58

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	3.23%
Operating Margin	6.42%
Return on Assets TTM	4.93%
Return on Equity TTM	14.18%

Income Statement

Revenue TTM	$183,124,000,768
Revenue per Share TTM	$795.76
Quarterly Revenue Growth	14.80%
Gross Profit TTM	$50,790,998,016
EBITDA	$9,834,999,808
Net Income to Common TTM	$5,917,000,192
Diluted EPS TTM	$25.68
Quarterly Earnings Growth YoY	-2.80%

Balance Sheet

Total Cash MRQ	$33,652,000,768
Total Cash per Share MRQ	$148.95
Total Debt MRQ	$
Total Debt to Equity MRQ	70.40
Current Ratio MRQ	1.43
Book Value per Share MRQ	$188.37

Cash Flow

Operating Cash Flow TTM	$4,847,000,064
Levered Free Cash Flow TTM	$7,437,749,760

ELV Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	227,479,695
Float Shares	225,423,988
Avg 10 Volume	1,889,685
Avg 30 Volume	None
Shares Short	2,503,358
Short Ratio	1.29
Short % of Shares	1.11%
% Held by Insiders	0.17%
% Held by Institutions	93.07%

Stock Price Summary

Beta	0.62
Fifty Two Week Low	$347.21
Fifty Two Week High	$567.26
Fifty Two Week Change	-52.46%
Day 50 MA	$393.71
Day 200 MA	$415.79

Dividends and Splits

Forward Annual Dividend Rate	$6.84
Forward Annual Dividend Yield	1.97%
Trailing Annual Dividend Rate	$6.60
Trailing Annual Dividend Yield	1.90%
Payout Ratio	25.68%
Dividend Date	2025-06-25
Ex Dividend Date	2025-06-10
Last Split Factor
Last Split Date	2005-06-01